Symbol
URGN on Nasdaq
Investment type
Equity / Ordinary Shares, par value NIS 0.01 per share
Latest Disclosed Ownership
839K shares
Security Ownership
1.8%

Monograph Capital Partners I, L.P. ownership in UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN)

2025-06-09 - Monograph Capital Partners I, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 839K shares of UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN). This represents 1.8% percent ownership of the company.